Department of Microbiology and Immunology, New York Medical College, Basic Science Building, Valhalla, NY, 10595, USA.
Microb Ecol. 2014 Aug;68(2):324-8. doi: 10.1007/s00248-014-0409-2. Epub 2014 Apr 24.
Marine bacteria from aquaculture areas with industrial use of quinolones have the potential to pass quinolone resistance genes to animal and human pathogens. The VPA0095 gene, related to the quinolone resistance determinant qnrA, from clinical isolates of epidemic Vibrio parahaemolyticus conferred reduced susceptibility to quinolone after cloning into Escherichia coli K-12 either when acting alone or synergistically with DNA gyrase mutations. In addition, a plasmid-mediated quinolone resistance gene from marine bacteria, aac(6')-Ib-cr, was identical to aac(6')-Ib-cr from urinary tract isolates of E. coli, suggesting a recent flow of this gene between these bacteria isolated from different environments. aac(6')-Ib-cr from E. coli also conferred reduced susceptibility to quinolone and kanamycin when cloned into E. coli K-12.
养殖区的海洋细菌在工业上使用喹诺酮类药物,有可能将喹诺酮类耐药基因传递给动物和人类病原体。从流行的副溶血性弧菌临床分离株中克隆到的 VPA0095 基因与喹诺酮类耐药决定簇 qnrA 有关,当它单独或与 DNA 回旋酶突变协同作用时,将大肠杆菌 K-12 中的克隆赋予对喹诺酮类药物的敏感性降低。此外,海洋细菌中介导喹诺酮类耐药的 aac(6')-Ib-cr 基因与来自大肠杆菌尿路感染分离株的 aac(6')-Ib-cr 完全相同,表明最近来自不同环境的这些细菌之间存在这种基因的流动。当将 aac(6')-Ib-cr 从大肠杆菌克隆到大肠杆菌 K-12 中时,它也会导致对喹诺酮类药物和卡那霉素的敏感性降低。